Zobrazeno 1 - 10
of 1 389
pro vyhledávání: '"De Veirman K"'
Autor:
Verheye E; Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.; Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Brussels Center of Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium., Kancheva D; Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Brussels Center of Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium., Satilmis H; Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium., Vandewalle N; Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium., Fan R; Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium., Bardet PMR; Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Brussels Center of Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium., Clappaert EJ; Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Brussels Center of Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium., Verstaen K; VIB Single Cell Core, VIB, Ghent-Louvain, Belgium.; Department of Biomedical Molecular Biology, Ghent University, 9052, Ghent, Belgium., De Becker A; Translational Oncology Research Center, Lab of Hematology and Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium., Vanderkerken K; Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium., De Veirman K; Translational Oncology Research Center, Lab of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium. Kim.De.Veirman@vub.be.; Translational Oncology Research Center, Lab of Hematology and Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium. Kim.De.Veirman@vub.be., Laoui D; Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium. dlaoui@vub.be.; Lab of Cellular and Molecular Immunology, Brussels Center of Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium. dlaoui@vub.be.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Nov 07; Vol. 17 (1), pp. 107. Date of Electronic Publication: 2024 Nov 07.
Autor:
Vandewalle N; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium., De Beule N; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Hematology Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels, 1090, Belgium., De Becker A; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Hematology Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels, 1090, Belgium., De Bruyne E; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium., Menu E; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium., Vanderkerken K; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium., Breckpot K; Translational Oncology Research Center (TORC), Team Laboratory of Cellular and Molecular Therapy (LMCT), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium., Devoogdt N; Laboratory of Molecular Imaging and Therapy (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium., De Veirman K; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium. Kim.De.Veirman@vub.be.; Translational Oncology Research Center (TORC), Team Hematology and Immunology (HEIM), Hematology Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels, 1090, Belgium. Kim.De.Veirman@vub.be.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2024 Oct 04; Vol. 13 (1), pp. 99. Date of Electronic Publication: 2024 Oct 04.
Autor:
Van der Vreken A; Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., Vanderkerken K; Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., De Bruyne E; Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., De Veirman K; Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., Breckpot K; Translational Oncology Research Center, Team Laboratory of Cellular and Molecular Therapy, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., Menu E; Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium. Eline.Menu@vub.be.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2024 Jul 10; Vol. 13 (1), pp. 66. Date of Electronic Publication: 2024 Jul 10.
Autor:
Wang Y; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium., Vandewalle N; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium., De Veirman K; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium.; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium., Vanderkerken K; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium., Menu E; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium. Eline.Menu@vub.be., De Bruyne E; Translational Oncology Research Center (TORC) - Team Hematology and Immunology (HEIM), Vrije Universiteit Brussel (VUB), Jette, Belgium. Elke.De.Bruyne@vub.be.
Publikováno v:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jun 11; Vol. 22 (1), pp. 320. Date of Electronic Publication: 2024 Jun 11.
Autor:
Hanssens H; Molecular Imaging and Therapy Research Group (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/K0, 1090 Brussels, Belgium., Meeus F; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/E2, 1090 Brussels, Belgium., Gesquiere EL; Molecular Imaging and Therapy Research Group (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/K0, 1090 Brussels, Belgium., Puttemans J; Molecular Imaging and Therapy Research Group (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/K0, 1090 Brussels, Belgium., De Vlaeminck Y; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/E2, 1090 Brussels, Belgium., De Veirman K; Laboratory for Hematology and Immunology (HEIM), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/D0, 1090 Brussels, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/E2, 1090 Brussels, Belgium., Devoogdt N; Molecular Imaging and Therapy Research Group (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103/K0, 1090 Brussels, Belgium.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 May 22; Vol. 25 (11). Date of Electronic Publication: 2024 May 22.
Autor:
Hanssens H; Laboratory of Molecular Imaging and Therapy (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium.; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium.; Laboratory for Hematology and Immunology (HEIM), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Meeus F; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., De Vlaeminck Y; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Lecocq Q; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Puttemans J; Laboratory of Molecular Imaging and Therapy (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Debie P; Laboratory of Molecular Imaging and Therapy (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., De Groof TWM; Laboratory of Molecular Imaging and Therapy (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Goyvaerts C; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., De Veirman K; Laboratory for Hematology and Immunology (HEIM), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy (LMCT), Translational Oncology Research Center, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Devoogdt N; Laboratory of Molecular Imaging and Therapy (MITH), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 19; Vol. 15, pp. 1389018. Date of Electronic Publication: 2024 Apr 19 (Print Publication: 2024).
Autor:
Vandewalle N; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., Satilmis H; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., Verheye E; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium.; Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.; Brussels Center of Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Fan R; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., Wang Y; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., De Groof TWM; Laboratory of Molecular Imaging and Therapy (MITH), Vrije Universiteit Brussel, Brussels, Belgium., Bridoux J; Laboratory of Molecular Imaging and Therapy (MITH), Vrije Universiteit Brussel, Brussels, Belgium., Kerre T; Department of Hematology, Ghent University Hospital, Ghent, Belgium., De Beule N; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Universitair Ziekenhuis Brussel, Brussels, Belgium., De Becker A; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Universitair Ziekenhuis Brussel, Brussels, Belgium., De Bruyne E; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., Menu E; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., Vanderkerken K; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium., Breckpot K; Translational Oncology Research Center (TORC), Laboratory for Molecular and Cellular Therapy (LMCT), Vrije Universiteit Brussel, Brussels, Belgium., Devoogdt N; Laboratory of Molecular Imaging and Therapy (MITH), Vrije Universiteit Brussel, Brussels, Belgium., De Veirman K; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium.; Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Universitair Ziekenhuis Brussel, Brussels, Belgium.
Publikováno v:
Theranostics [Theranostics] 2024 Apr 15; Vol. 14 (7), pp. 2656-2674. Date of Electronic Publication: 2024 Apr 15 (Print Publication: 2024).
Autor:
Wang Y; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette., Muylaert C; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette., Wyns A; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette., Vlummens P; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette, Belgium; Department of Clinical Hematology, Ghent University Hospital - Gent., De Veirman K; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette., Vanderkerken K; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette., Zaal E; Utrecht Metabolism Expertise Centre, Nieuw Gildestein - Utrecht., Berkers C; Utrecht Metabolism Expertise Centre, Nieuw Gildestein - Utrecht., Moreaux J; Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier - Montpellier, France; Institute of Human Genetics, University of Montpellier - Montpellier, France; Institut Universitaire de France - Paris., De Bruyne E; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette. Elke.De.Bruyne@vub.be., Menu E; Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel - Jette. Eline.Menu@vub.be.
Publikováno v:
Haematologica [Haematologica] 2024 Jan 01; Vol. 109 (1), pp. 256-271. Date of Electronic Publication: 2024 Jan 01.
Autor:
Fan R; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium., Satilmis H; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium., Vandewalle N; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium., Verheye E; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Laboratory of Myeloid Cell Immunology, VIB Center for Inflammation Research, Pleinlaan 2, 1050, Brussels, Belgium., De Bruyne E; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium., Menu E; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium., De Beule N; Department of Clinical Hematology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium. Laarbeeklaan 101, 1090, Brussel, Belgium., De Becker A; Department of Clinical Hematology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium. Laarbeeklaan 101, 1090, Brussel, Belgium., Ates G; Neuro-Aging & Viro-Immunotherapy, Center for Neurosciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussel, Belgium., Massie A; Neuro-Aging & Viro-Immunotherapy, Center for Neurosciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussel, Belgium., Kerre T; Department of Hematology, Ghent University Hospital, Faculty of Medicine and Health Sciences, Ghent University, 9000, Ghent, Belgium., Törngren M; Active Biotech AB, Lund, Sweden. Scheelevägen 22, 22363, Lund, Sweden., Eriksson H; Active Biotech AB, Lund, Sweden. Scheelevägen 22, 22363, Lund, Sweden., Vanderkerken K; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium., Breckpot K; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussel, Belgium., Maes K; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium.; Clinical Sciences, Research Group Reproduction and Genetics, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 103, 1090, Brussel, Belgium., De Veirman K; Laboratory for Hematology and Immunology, Department of Biomedical Sciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium. Kim.De.Veirman@vub.be.; Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Building D, 1090, Brussel, Belgium. Kim.De.Veirman@vub.be.; Department of Clinical Hematology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium. Laarbeeklaan 101, 1090, Brussel, Belgium. Kim.De.Veirman@vub.be.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Dec 18; Vol. 13 (1), pp. 188. Date of Electronic Publication: 2023 Dec 18.
Autor:
Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany., Benes V; Europäisches Laboratorium für Molekularbiologie, GeneCore, Heidelberg, Germany., Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and St. Georg, Hamburg, Germany., Bertsch U; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany., Scheid C; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz GmbH, Chemnitz, Germany., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hielscher T; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany., Raab MS; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany., Goldschmidt H; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Jauch A; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany., Maes K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., De Bruyne E; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Menu E; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., De Veirman K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Moreaux J; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Vanderkerken K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Nov 15; Vol. 14, pp. 1286700. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).